Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy
A pulmonary carcinoid tumor is a rare tumor that lacks a validated therapeutic approach for unresectable disease. Understanding the intersite tumor‐immune heterogeneity is essential to harness the immune system for cancer therapy. However, little is known about the tumor‐immune microenvironment (TIM...
Main Authors: | Shinya Sakata, Kosuke Imamura, Yuka Tajima, Yuiko Masuda, Ryo Sato, Chieko Yoshida, Shinichiro Okamoto, Sho Saeki, Yusuke Tomita, Takuro Sakagami |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13772 |
Similar Items
-
Gastrointestinal carcinoid tumors Tumores carcinoides digestivos
by: M. J. Varas Lorenzo, et al.
Published: (2010-09-01) -
ILEUS CAUSED BY CARCINOID TUMOR OF SMALL INTESTINE - A CASE REPORT
by: Saša Dragović, et al.
Published: (2012-09-01) -
Primary carcinoid tumor in the external auditory canal
by: Dong Hae Chung, et al.
Published: (2020-03-01) -
Primary carcinoid tumors at atypical sites: surgery is mandatory and size determines survival—an Egyptian study
by: Karim G. Moustafa, et al.
Published: (2019-02-01) -
Primary carcinoid tumor of the kidney: Case report and brief review of literature
by: Jain Deepali, et al.
Published: (2010-10-01)